1Tse Y, Levine V J, McClain SA, et al. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q- switched neodymium: yttrium-aluminum-garnet laser. A comparative study [J]. J Dermatol Surg Oncol, 1994, 20(12): 795-800.
2Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Qswitched ruby laser[J]. J Dermatol Surg Oncol, 1994, 20(9): 592-597.
3Jang WS, Lee CK, Kim BJ, et al. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients[J]. Dermatol Surg, 2011, 37(8): 1133-1140.
5Pandya AG, Hynan LS, Bhore R, et al. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method [J]. J Am Acad Dermatol, 2011, 64(1 ): 78-83, 83.el-2.
6Sheth VM, Pandya AG. Melasma: a comprehensive update: part I[J]. J Am Acad Dermatol, 2011, 65(4): 689-697.
7Chang C J, Kou CS. Comparing the effectiveness of Q-switched Ruby laser treatment with that of Q-switched Nd:YAG laser for oeulodermal melanosis (Nevus of Ota)[J]. J Plast Reeonstr Aesthet Surg, 2011, 64(3): 339-345.
7A1-Dhalimi MA, Maluki AH,Tauma A.Efficacy and safe- ty of 532-nm and 1,064-nm Q-switched Nd : YAG laser treatment of frictional dermal melanosis over bony prominences (lifa disease) [J].Dermatol Surg, 2015,41 ( 1 ) : 136-141.
8Jalaly NY,Valizadeh N,Barikbin B,et al. Low power fractional CO2 laser versus low-fluence Q-switch 1064 nm Nd:YAG laser for treatment of melasma:a randomized, controlled,split face study [J]. Am J Clin Dermatol,2014,15 (4) : 357-363.
9Lee SM,Kim MS,Kim YJ,et al. Adverse events of non- ablative fractional laser photothermolysis:a retrospective study of 856 treatments in 362 patients - J Dermatolog Treat, 2014,25(4) : 304-307.
10Lee HM, Haw S, Kim JK,et al. Split-face study using a 1,927-nm thulium fiber fractional laser to treat photoaging and melasma in Asian skin [J]. Dermatol Surg, 2013,39(6) : 879-888.
